Nancy Alexi, Ph.D.

Senior leader in Project, Program & Portfolio Management

With a distinguished career spanning over three decades, Nancy Alexi has been a leading figure in biopharmaceutical project management. Her experience in drug development, coupled with her passion for innovation, has driven programs from preclinical to commercialization.

Nancy has held key positions at Kartos Therapeutics, Telios Pharma, Sanofi (Principia Biopharma), Rain Oncology, Aimmune Therapeutics, Affymax, Genelabs Technologies, and Baxter Bioscience. Her ability to navigate complex therapeutic landscapes, and implement effective management strategies, has been instrumental in streamlining operations as well as the development of high value assets.

Nancy is a dedicated mentor and collaborator. Her infectious enthusiasm and commitment to foster a positive work environment have inspired many. Her ability to build high-performing teams has been a hallmark of her leadership style.

Nancy holds a Ph.D. in Microbiology from the University of Reading (UK) and a B.Sc. (Honors) in Microbiology from University of Kent at Canterbury (UK). Her deep understanding of drug development provides a solid foundation for her work in project management.

Nancy is a passionate advocate for project management advancement and has been a member of BioPharmaPM organization and on the conference planning committee for a number of years. She was the co-chair for the 2020 and 2024 annual conference. She recently joined the BiopPharmaPM Board of Directors where she aims to educate, innovate, and make impactful changes to the project management landscape.

Greg Cohee, MBA

Greg Cohee is a scientist and seasoned business professional with over thirty years of pharmaceutical industry experience working across various drug development functions, including discovery, clinical operations, and program management, at both large pharmaceutical and small biotech companies.  His expertise encompasses project management, portfolio and resource management, process improvement, cross-functional team collaboration, data analytics and visualization, as well as technology strategy development and implementation.

Throughout his career, Greg has leveraged his scientific knowledge and business acumen to facilitate the development and launch of commercial products, as well as help build several successful start-up companies.  Over the last two decades, Greg was a Managing Partner for a successful consulting firm, while also serving as the Vice President of R&D Solutions, for an eClinical company, providing software products to support Clinical Trial Operations and Resource Demand Forecasting capabilities.

Greg received his B.S. in Chemistry and M.B.A. in Finance from Rider University and is the holder of three U.S. and one European patents. Currently, he serves on the Board of Directors for BioPharmaPM, a nonprofit organization dedicated to the strategic adaptation of project management competencies for evolving biopharma needs.